These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 28754431)
1. Recommendations of the Brazilian Society of Rheumatology for the induction therapy of ANCA-associated vasculitis. Souza AWS; Calich AL; Mariz HA; Ochtrop MLG; Bacchiega ABS; Ferreira GA; Rêgo J; Perez MO; Pereira RMR; Bernardo WM; Levy RA Rev Bras Reumatol Engl Ed; 2017; 57 Suppl 2():484-496. PubMed ID: 28754431 [TBL] [Abstract][Full Text] [Related]
2. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Chung SA; Langford CA; Maz M; Abril A; Gorelik M; Guyatt G; Archer AM; Conn DL; Full KA; Grayson PC; Ibarra MF; Imundo LF; Kim S; Merkel PA; Rhee RL; Seo P; Stone JH; Sule S; Sundel RP; Vitobaldi OI; Warner A; Byram K; Dua AB; Husainat N; James KE; Kalot MA; Lin YC; Springer JM; Turgunbaev M; Villa-Forte A; Turner AS; Mustafa RA Arthritis Care Res (Hoboken); 2021 Aug; 73(8):1088-1105. PubMed ID: 34235880 [TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type. Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U; Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483 [TBL] [Abstract][Full Text] [Related]
4. CanVasc consensus recommendations for the use of avacopan in antineutrophil cytoplasm antibody-associated vasculitis: 2022 addendum. Turgeon D; Bakowsky V; Baldwin C; Cabral DA; Clements-Baker M; Clifford A; Cohen Tervaert JW; Dehghan N; Ennis D; Famorca L; Fifi-Mah A; Girard LP; Lefebvre F; Liang P; Makhzoum JP; Massicotte-Azarniouch D; Mendel A; Milman N; Reich HN; Robinson DB; Ross C; Rumsey DG; Soowamber M; Towheed TE; Trudeau J; Twilt M; Yacyshyn E; Yardimci GK; Khalidi N; Barra L; Pagnoux C Rheumatology (Oxford); 2023 Aug; 62(8):2646-2651. PubMed ID: 36805625 [TBL] [Abstract][Full Text] [Related]
5. Systematic review and meta-analysis for 2017 clinical practice guidelines of the Japan research committee of the ministry of health, labour, and welfare for intractable vasculitis for the management of ANCA-associated vasculitis. Nagasaka K; Harigai M; Hagino N; Hara A; Horita T; Hayashi T; Itabashi M; Ito S; Katsumata Y; Kawashima S; Naniwa T; Sada KE; Nango E; Nakayama T; Tsutsumino M; Yamagata K; Homma S; Arimura Y Mod Rheumatol; 2019 Jan; 29(1):119-129. PubMed ID: 29996690 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic algorithm for antineutrophil cytoplasmic antibody-associated systemic vasculitis. Beketova TV Ter Arkh; 2018 May; 90(5):13-22. PubMed ID: 30701885 [TBL] [Abstract][Full Text] [Related]
13. Consensus Treatment Plans for Severe Pediatric Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Morishita KA; Wagner-Weiner L; Yen EY; Sivaraman V; James KE; Gerstbacher D; Szymanski AM; O'Neil KM; Cabral DA; Arthritis Care Res (Hoboken); 2022 Sep; 74(9):1550-1558. PubMed ID: 33675161 [TBL] [Abstract][Full Text] [Related]
14. [Recommendations on the use of rituximab for ANCA-associated vasculitis]. Gause AM; Rubbert-Roth A; Z Rheumatol; 2014 Apr; 73(3):287-9. PubMed ID: 27039911 [TBL] [Abstract][Full Text] [Related]
15. The utility of the ACR/EULAR 2017 provisional classification criteria for granulomatosis with polyangiitis in Korean patients with antineutrophil cytoplasmic antibody-associated vasculitis. Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW Clin Exp Rheumatol; 2018; 36 Suppl 111(2):85-87. PubMed ID: 29185957 [TBL] [Abstract][Full Text] [Related]
16. Current clinical evidence of tocilizumab for the treatment of ANCA-associated vasculitis: a prospective case series for microscopic polyangiitis in a combination with corticosteroids and literature review. Sakai R; Kondo T; Kurasawa T; Nishi E; Okuyama A; Chino K; Shibata A; Okada Y; Takei H; Nagasawa H; Amano K Clin Rheumatol; 2017 Oct; 36(10):2383-2392. PubMed ID: 28733791 [TBL] [Abstract][Full Text] [Related]
17. 2017 Clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of ANCA-associated vasculitis. Harigai M; Nagasaka K; Amano K; Bando M; Dobashi H; Kawakami T; Kishibe K; Murakawa Y; Usui J; Wada T; Tanaka E; Nango E; Nakayama T; Tsutsumino M; Yamagata K; Homma S; Arimua Y Mod Rheumatol; 2019 Jan; 29(1):20-30. PubMed ID: 30001655 [TBL] [Abstract][Full Text] [Related]
18. Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association Registry. Hruskova Z; Stel VS; Jayne D; Aasarød K; De Meester J; Ekstrand A; Eller K; Heaf JG; Hoitsma A; Martos Jimenéz C; Ravani P; Wanner C; Tesar V; Jager KJ Am J Kidney Dis; 2015 Oct; 66(4):613-20. PubMed ID: 25975963 [TBL] [Abstract][Full Text] [Related]
19. CanVasc Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitides. McGeoch L; Twilt M; Famorca L; Bakowsky V; Barra L; Benseler SM; Cabral DA; Carette S; Cox GP; Dhindsa N; Dipchand CS; Fifi-Mah A; Goulet M; Khalidi N; Khraishi MM; Liang P; Milman N; Pineau CA; Reich HN; Samadi N; Shojania K; Taylor-Gjevre R; Towheed TE; Trudeau J; Walsh M; Yacyshyn E; Pagnoux C; J Rheumatol; 2016 Jan; 43(1):97-120. PubMed ID: 26523024 [TBL] [Abstract][Full Text] [Related]